Information about SaveRxCanada.to
List of countries where we can ship Lixisenatide:
Latest news releases on Lixisenatide:
Lixisenatide; Clinical data; Trade names: Lyxumia (Europe), Adlyxin (US) License data
Lyxumia and other lixisenatide is an injection used to treat type 2 diabetes.
Lixisenatide is a recombinant DNA produced polypeptide analogue of human glucagon-like peptide-1 (GLP-1) which is used in combination with diet and exercise in the ...
Lixisenatide (Adlyxin) is a drug prescribed to treat type 2 diabetes in conjunction with diet and exercise. Side effects include hypoglycemia, dizziness, diarrhea ...
Indications, dose, contra-indications, side-effects, interactions, cautions, warnings and other safety information for LIXISENATIDE.
BackgroundCardiovascular morbidity and mortality are higher among patients with type 2 diabetes, particularly those with concomitant cardiovascular diseases, than in ...
This video shows you how to pronounce Lixisenatide
The U.S. Food and Drug Administration approved Adlyxin (lixisenatide), a once-daily injection to improve glycemic control (blood sugar levels), along with diet and ...
Concomitant medicinal products The delay of gastric emptying with lixisenatide may reduce the rate of absorption of orally administered medicinal products.
FDA approval history for Adlyxin (lixisenatide) used to treat Diabetes, Type 2. Supplied by Sanofi